Posted in | News | Mining Business

Zenyatta Ventures Announces Commencement of Drilling on the East Pipe

Zenyatta Ventures Ltd. (“Zenyatta” or “Company”) is pleased to announce that a second drill rig has commenced drilling on the East Pipe with a larger drill (HQ size) in order to obtain 5 tonnes of graphite mineralization to proceed with a second phase processing of a mini-bulk sample at SGS Canada Inc. (‘SGS’) in Lakefield.

This processing will allow additional optimization of the flow sheet for the preliminary economic assessment (PEA) and provide material for further testing by Zenyatta and interested parties who have requested material.

Aubrey Eveleigh, President and CEO stated “Zenyatta is presently testing the high purity graphitic material at labs and universities in North America and should have information available for release in September. In the meantime, the Company has been approached by many global corporations and academic institutions requesting Zenyatta’s unique ultra-high purity graphite material for testing in their own labs. Additional processing at SGS will provide enough ultra-high purity material for release to these various parties.”

Eveleigh further stated “Both pipes continue to demonstrate the exceptional continuity and size potential of the graphite deposit, and the outline of each pipe correlates well with the shape of the conductivity anomalies defined by the ground EM survey. The current drill campaign is designed to allow for a NI 43-101 compliant resource estimate by RPA (formerly Roscoe Postle & Associates Inc.) for both the East and West pipes. Drilling is on schedule for a NI 43-101 statement in early 4Q/13.”

Zenyatta expects to release additional drill results for the West and East pipes soon.

Mr. Peter Wood, P.Geo., VP Exploration, is the “Qualified Person” under NI 43-101 and has reviewed the technical information contained in this news release. To find out more on Zenyatta Ventures Ltd., please visit website www.zenyatta.ca or contact the Company at [email protected] or Tel. 807-346-1660.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.